Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
May, 11 2025
Dec, 1 2025
Sep, 30 2025
May, 27 2026
Dec, 29 2025